Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

<jats:sec><jats:title>Objective</jats:title><jats:p>Somatotroph adenomas causing acromegaly are histologically classified into densely granulated (DG) and sparsely granulated (SG) subtypes with different morphology, clinical characteristics and treatment outcomes. Granulation pattern has been reported to co-segregate with a recurrent mutation at codon 49 in growth hormone receptor (<jats:italic>GHR</jats:italic>) and <jats:italic>GSP</jats:italic> oncogene. This study examines response to the octreotide suppression test (OST) in relation to granulation pattern and mutation in <jats:italic>GHR</jats:italic> and <jats:italic>GSP</jats:italic>.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>This is a retrospective, single-centre study of 52 patients with pathologically confirmed somatotroph adenoma who were naïve to medical therapy presenting between January 2001 and October 2010.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Clinical, radiological and hormonal data at diagnosis were recorded. <jats:italic>GHR</jats:italic> and <jats:italic>GSP</jats:italic> were genotyped, granulation pattern determined and response to the OST measured.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>SG adenomas were larger (<jats:italic>P</jats:italic>=0.038), occurred in younger patients (<jats:italic>P</jats:italic>=0.029), were more common in females (<jats:italic>P</jats:italic>=0.026) and were more invasive (<jats:italic>P</jats:italic>&lt;0.0001 and <jats:italic>P</jats:italic>=0.001), with diminished responses to the OST (<jats:italic>P</jats:italic>=0.007) compared with DG adenomas. <jats:italic>GSP</jats:italic> mutation was unrelated to granulation pattern but associated with smaller tumours (<jats:italic>P</jats:italic>=0.027), producing more GH (<jats:italic>P</jats:italic>=0.048) that responded better to the OST (<jats:italic>P</jats:italic>=0.022). Codon 49 of <jats:italic>GHR</jats:italic> was not mutated.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Adenoma histological phenotype, not genotype, corresponds to clinical and biochemical characteristics and response to the OST. SG adenomas constitute a clinically more unfavourable subtype but are not associated with <jats:italic>GHR</jats:italic> mutations in our series. Ascertainment of the adenoma subtype may become an important consideration in the management of acromegaly.</jats:p></jats:sec>

Original publication




Journal article


European Journal of Endocrinology



Publication Date





491 - 499